| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 1.07e-04 | 2 | 194 | 2 | 1.20.1420.10 | |
| Domain | VBS | 1.07e-04 | 2 | 194 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 1.07e-04 | 2 | 194 | 2 | IPR015009 | |
| Domain | Talin_cent | 1.07e-04 | 2 | 194 | 2 | IPR015224 | |
| Domain | Talin_middle | 1.07e-04 | 2 | 194 | 2 | PF09141 | |
| Domain | BAT2_N | 3.20e-04 | 3 | 194 | 2 | PF07001 | |
| Domain | TACC | 3.20e-04 | 3 | 194 | 2 | PF05010 | |
| Domain | Talin-1 | 3.20e-04 | 3 | 194 | 2 | IPR015710 | |
| Domain | BAT2_N | 3.20e-04 | 3 | 194 | 2 | IPR009738 | |
| Domain | TACC | 3.20e-04 | 3 | 194 | 2 | IPR007707 | |
| Domain | PRRC2 | 3.20e-04 | 3 | 194 | 2 | IPR033184 | |
| Domain | Cadherin_2 | 5.72e-04 | 65 | 194 | 5 | PF08266 | |
| Domain | Cadherin_N | 5.72e-04 | 65 | 194 | 5 | IPR013164 | |
| Domain | ILWEQ_dom | 6.35e-04 | 4 | 194 | 2 | IPR002558 | |
| Domain | ILWEQ | 6.35e-04 | 4 | 194 | 2 | SM00307 | |
| Domain | Nucleoside_tran | 6.35e-04 | 4 | 194 | 2 | PF01733 | |
| Domain | FERM_f0 | 6.35e-04 | 4 | 194 | 2 | PF16511 | |
| Domain | ILWEQ | 6.35e-04 | 4 | 194 | 2 | PD011820 | |
| Domain | - | 6.35e-04 | 4 | 194 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 6.35e-04 | 4 | 194 | 2 | PF01608 | |
| Domain | I_LWEQ | 6.35e-04 | 4 | 194 | 2 | PS50945 | |
| Domain | FERM_f0 | 6.35e-04 | 4 | 194 | 2 | IPR032425 | |
| Domain | Eqnu_transpt | 6.35e-04 | 4 | 194 | 2 | IPR002259 | |
| Domain | Cadherin_C | 9.28e-04 | 42 | 194 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 9.28e-04 | 42 | 194 | 4 | PF16492 | |
| Domain | NUT | 1.05e-03 | 5 | 194 | 2 | IPR024310 | |
| Domain | NUT_N | 1.05e-03 | 5 | 194 | 2 | IPR024309 | |
| Domain | NUT | 1.05e-03 | 5 | 194 | 2 | PF12881 | |
| Domain | FERM_M | 1.31e-03 | 46 | 194 | 4 | PF00373 | |
| Domain | UBA | 1.42e-03 | 47 | 194 | 4 | PS50030 | |
| Domain | Alpha_kinase | 1.57e-03 | 6 | 194 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 1.57e-03 | 6 | 194 | 2 | IPR004166 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.57e-03 | 6 | 194 | 2 | IPR016332 | |
| Domain | Glyco_hydro_13 | 1.57e-03 | 6 | 194 | 2 | IPR015902 | |
| Domain | ALPHA_KINASE | 1.57e-03 | 6 | 194 | 2 | PS51158 | |
| Domain | Alpha_kinase | 1.57e-03 | 6 | 194 | 2 | SM00811 | |
| Domain | - | 1.66e-03 | 49 | 194 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.66e-03 | 49 | 194 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.66e-03 | 49 | 194 | 4 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.79e-03 | 50 | 194 | 4 | IPR014352 | |
| Domain | FERM_1 | 1.79e-03 | 50 | 194 | 4 | PS00660 | |
| Domain | FERM_2 | 1.79e-03 | 50 | 194 | 4 | PS00661 | |
| Domain | FERM_3 | 1.79e-03 | 50 | 194 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.79e-03 | 50 | 194 | 4 | IPR019749 | |
| Domain | B41 | 1.79e-03 | 50 | 194 | 4 | SM00295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 ABL1 PPRC1 MAML1 DACT1 CYREN ZBED4 COBL TLN2 UNKL DENND5A CAMSAP1 ARHGAP21 PRRC2B SMG6 EPN3 MEX3D NSD1 NUP214 REV3L FAAP100 ATP13A2 SLC1A5 MADD NBPF1 HIVEP3 LATS2 ZNF827 INF2 TLN1 EHMT1 MAPKBP1 SNAPC4 | 1.36e-14 | 1105 | 203 | 33 | 35748872 |
| Pubmed | AVL9 PPRC1 CSMD3 PLEKHH1 ZBED4 COBL KATNIP ARHGAP21 PRRC2B NUP214 MADD MAP7D1 TLN1 PDE4DIP PPIP5K1 CIPC MAPKBP1 SRRM2 PDZD2 | 4.39e-12 | 407 | 203 | 19 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 ABL1 MAP2 TRPM7 BACH1 CDCA2 HAUS8 NF1 SQSTM1 COBL CAMSAP1 ARHGAP21 ANKS1A STIM2 HIPK4 PPFIBP1 SLC1A5 MADD VPS13D MAP7D1 KIAA1217 PLCH1 SRRM2 CSPP1 SNX2 OTOG | 8.69e-12 | 861 | 203 | 26 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 CAAP1 PDE4C BRIP1 BACH1 BCOR NF1 PTPRC ZBTB40 TLN2 KDM6A PRRC2A UNC5D ANKS1A CAST NUP214 PALB2 YLPM1 SENP6 SNAPC4 SRRM2 ZMYM4 SNX2 TP53BP1 | 3.40e-11 | 774 | 203 | 24 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 GAK NACA BCOR DDX10 PARP1 TACC1 PRR14L CAMSAP1 PRRC2A PLRG1 ARHGAP21 PRRC2B ANKS1A CAST TACC2 NUP214 SLC1A5 SLC3A2 ARID2 KIAA1217 TLN1 YLPM1 PAK2 SENP6 TP53BP1 | 5.16e-11 | 934 | 203 | 26 | 33916271 |
| Pubmed | GAK TRPM7 SLC30A1 BASP1 TACC1 PRR14L CAMSAP1 STIM2 PPFIBP1 CAST NUP214 CRKL SLC3A2 JPH1 SLC7A2 RAB3GAP1 VPS13D INF2 TLN1 SNX2 | 1.81e-10 | 568 | 203 | 20 | 37774976 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP2 ZC3H8 ADGRV1 TASOR2 PLEKHH1 COBL KATNIP DENND5A KDM6A SMG6 ANKS1A CDC42BPG EPB41L4B CAST WDR27 NAALADL2 CEP43 NBPF1 HIVEP3 USF3 ATP2C1 LATS2 ZNF827 INF2 KIAA1217 EHMT1 ZFHX3 PNPLA7 PRDM15 ZMYM4 SNX2 PDZD2 | 1.96e-10 | 1489 | 203 | 32 | 28611215 |
| Pubmed | NOLC1 ANKS6 TRPM7 MAML1 SLC30A1 TASOR2 CDCA2 BASP1 SQSTM1 TACC1 CAMSAP1 ARHGAP21 PRRC2B AVEN STIM2 EPB41L4B PPFIBP1 SLC1A5 SLC3A2 LIPE DTWD2 EHMT1 ZFHX3 | 2.22e-10 | 777 | 203 | 23 | 35844135 | |
| Pubmed | NOLC1 GAP43 MAP2 CNST NACA BACH1 COPB2 SLC30A1 NF1 BASP1 SQSTM1 TLN2 TACC1 CAMSAP1 STIM2 MAGED1 PCLO TACC2 MADD CRKL SLC3A2 RAB3GAP1 CACNG8 ATP2C1 KIAA1217 PDE4DIP TP53BP1 | 7.38e-10 | 1139 | 203 | 27 | 36417873 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ANKS6 TRPM7 SLC30A1 NF1 PCDH11X COBL CAMSAP1 ARHGAP21 EPN3 STIM2 EPB41L4B PPFIBP1 CDCP1 SLC1A5 SLC3A2 JPH1 SLC7A2 LATS2 SLC29A1 | 1.27e-09 | 569 | 203 | 19 | 30639242 |
| Pubmed | GAK BRIP1 NACA MAML1 SLC30A1 HAUS8 SQSTM1 TACC1 PRR14L CAMSAP1 ANKS1A TANK MAGED1 HYOU1 VPS50 NUP214 MADD SLC3A2 JPH1 YLPM1 PLCH1 | 2.52e-09 | 733 | 203 | 21 | 34672954 | |
| Pubmed | NOLC1 GAK MAP2 TRPM7 BACH1 BCKDHA SLC30A1 DDX10 UBE4A PARP1 BASP1 TACC1 PLRG1 STIM2 MAGED1 HYOU1 PPFIBP1 SLC1A5 SLC3A2 JPH1 RAB3GAP1 INF2 TLN1 EHMT1 PLCH1 SRRM2 CSPP1 SNX2 TP53BP1 NIN | 3.34e-09 | 1487 | 203 | 30 | 33957083 | |
| Pubmed | TRPM7 CNST PPRC1 BACH1 SYNC RXRG PLEKHH1 TRIM66 UBE4A PARP1 TLN2 KDM6A PRRC2A ARHGAP21 MAGED1 PPFIBP1 ADNP2 REV3L SEC31B MADD JPH1 PDE4DIP YLPM1 PAK2 SENP6 CIPC ZMYM4 | 9.55e-09 | 1285 | 203 | 27 | 35914814 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CAAP1 COPB2 DDX10 HAUS8 BASP1 SQSTM1 CAMSAP1 PRRC2A PLRG1 PRRC2B AVEN MAGED1 HYOU1 EPB41L4B CAST MAP7D1 TLN1 YLPM1 EHMT1 PAK2 | 1.13e-08 | 724 | 203 | 20 | 36232890 |
| Pubmed | NOLC1 CNST PPRC1 DZIP1L COPB2 BCOR PTPRC SQSTM1 ZBTB40 CRYBG1 STK24 ARHGAP21 HYOU1 EPB41L4B CAST NSD1 TACC2 CDCP1 MADD INF2 SLTM CIPC SLC29A1 TP53BP1 | 2.57e-08 | 1084 | 203 | 24 | 11544199 | |
| Pubmed | MYSM1 TRIM66 UBE4A STIM2 TBC1D30 PPFIBP1 FANCM HIVEP3 RAB3GAP1 VPS13D USF3 ATP2C1 ARID2 DNAH17 FHDC1 PLCH1 | 4.00e-08 | 493 | 203 | 16 | 15368895 | |
| Pubmed | NOLC1 CAAP1 DCDC1 BCKDHA BCOR ZNF518A TRIM66 SQSTM1 TAF4B UNC5D PRRC2B VPS50 ADNP2 REV3L JPH1 MAP7D1 ATP2C1 ZNF827 ARID2 EHMT1 ZFHX3 LONRF3 SRRM2 NIN | 4.42e-08 | 1116 | 203 | 24 | 31753913 | |
| Pubmed | SQSTM1 TACC1 CAMSAP1 ARHGAP21 PRRC2B ANKS1A STIM2 MAGED1 HYOU1 EPB41L4B LATS2 KIAA1217 | 5.57e-08 | 263 | 203 | 12 | 34702444 | |
| Pubmed | COPB2 BCKDHA BCOR SLC30A1 CDCA2 PARP1 PTPRC BASP1 PHLPP1 KDM6A PRRC2A PRRC2B HYOU1 SLC1A5 MADD SLC3A2 YLPM1 SLTM CDC25A SRRM2 CSPP1 SLC29A1 NIN | 6.10e-08 | 1049 | 203 | 23 | 27880917 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 NACA BACH1 COPB2 TASOR2 HAUS8 SQSTM1 TLN2 PLRG1 PRRC2B TACC2 NUP214 FAAP100 CEP43 JPH1 MISP MAP7D1 INF2 ARID2 TLN1 YLPM1 EHMT1 ZMYM4 TP53BP1 | 8.35e-08 | 1155 | 203 | 24 | 20360068 |
| Pubmed | NOLC1 PHF19 ZNF831 TASOR2 HAUS8 CRYBG1 KDM6A PLRG1 ANKS1A MAGED1 NUP214 SLTM EHMT1 ZMYM4 TP53BP1 | 1.30e-07 | 469 | 203 | 15 | 27634302 | |
| Pubmed | GAK ANKS6 AVL9 SQSTM1 AP3M2 COBL DENND5A TBC1D30 VPS50 TACC2 SLC3A2 SNX2 | 1.33e-07 | 285 | 203 | 12 | 34369648 | |
| Pubmed | GAK BCOR KDM6A PRRC2A PRRC2B CAST NSD1 CRKL SLC3A2 ARID2 TLN1 YLPM1 PAK2 ZMYM4 SNX2 TP53BP1 | 1.72e-07 | 549 | 203 | 16 | 38280479 | |
| Pubmed | TRPM7 PRRC2A STIM2 NUP214 SLC1A5 SLC3A2 JPH1 INF2 TLN1 YLPM1 | 2.06e-07 | 191 | 203 | 10 | 31177093 | |
| Pubmed | COPB2 SLC30A1 PARP1 CAMSAP1 PRRC2A ARHGAP21 ANKS1A STIM2 HYOU1 PPFIBP1 NUP214 SLC1A5 CRKL SLC3A2 JPH1 TLN1 PAK2 PLCH1 | 2.16e-07 | 708 | 203 | 18 | 39231216 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 CAAP1 BRIP1 BCOR TASOR2 DDX10 CDCA2 PARP1 PRRC2A PLRG1 CAST NSD1 NUP214 FANCM ARID2 YLPM1 SLTM SENP6 SRRM2 ZMYM4 TP53BP1 | 2.23e-07 | 954 | 203 | 21 | 36373674 |
| Pubmed | GAP43 MAP2 NACA SQSTM1 COBL KDM6A ANKS1A AVEN CRKL PLCH1 SRRM2 | 2.47e-07 | 246 | 203 | 11 | 15345747 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SLC30A1 CRYBG1 STK24 ARHGAP21 EPN3 EPB41L4B PPFIBP1 CAST NUP214 SLC1A5 CRKL SLC3A2 KIAA1217 TLN1 PAK2 SNX2 | 2.53e-07 | 565 | 203 | 16 | 25468996 |
| Pubmed | MAP2 TASOR2 TAF4B PRRC2A UNC5D VTN TANK PCDHGA3 PPFIBP1 PCLO SLC3A2 MAP7D1 SLTM LONRF3 DISP1 | 2.65e-07 | 496 | 203 | 15 | 31343991 | |
| Pubmed | NOLC1 NACA COPB2 MAML1 BCOR DDX10 CDCA2 BASP1 SQSTM1 ZBTB40 KDM6A PRRC2A PRRC2B FOXI1 MAGED1 NUP214 SLC1A5 MAP7D1 ARID2 YLPM1 EHMT1 ZFHX3 EN1 SRRM2 ZMYM4 TP53BP1 | 3.07e-07 | 1429 | 203 | 26 | 35140242 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NACA SLC30A1 CDCA2 BASP1 SQSTM1 PHLPP1 NUP214 SLC1A5 SLC3A2 MISP TLN1 | 3.67e-07 | 256 | 203 | 11 | 33397691 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | METTL3 GAK MAML1 BCOR SQSTM1 PLRG1 PRRC2B MAGED1 VPS50 TACC2 ARID2 KIAA1217 SENP6 ZMYM4 TP53BP1 NIN | 4.30e-07 | 588 | 203 | 16 | 38580884 |
| Pubmed | SQSTM1 COBL CAMSAP1 ARHGAP21 ANKS1A PPFIBP1 CEP43 MISP VPS13D SNX2 | 4.73e-07 | 209 | 203 | 10 | 36779422 | |
| Pubmed | ABL1 MYSM1 PARP1 ZBED4 TACC1 CAMSAP1 PRRC2A PRRC2B NSD1 CDCP1 TLN1 ALPK2 | 6.78e-07 | 332 | 203 | 12 | 37433992 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 7.73e-07 | 13 | 203 | 4 | 17920017 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 15207008 | ||
| Pubmed | ADGRV1 ZNF518A ZBTB40 PHLPP1 TLN2 SMG6 PPFIBP1 TLN1 EHMT1 NIN | 9.27e-07 | 225 | 203 | 10 | 12168954 | |
| Pubmed | BCOR PARP1 NF1 BASP1 TLN2 CAMSAP1 PRRC2A ARHGAP21 PRRC2B SMG6 ANKS1A MAGED1 NSD1 MAP7D1 KIAA1217 PDE4DIP YLPM1 EHMT1 PAK2 TP53BP1 | 1.08e-06 | 963 | 203 | 20 | 28671696 | |
| Pubmed | NACA CARD6 DENND5A PLRG1 ARHGAP21 PRRC2B CDC42BPG VTN MAGED1 HYOU1 EPB41L4B PPFIBP1 MADD MAP7D1 SLTM PLCH1 | 1.59e-06 | 650 | 203 | 16 | 38777146 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 NF1 TLN2 CAMSAP1 PRRC2A PRRC2B EPB41L4B CDCP1 MAP7D1 SLTM SRRM2 ZMYM4 | 1.62e-06 | 361 | 203 | 12 | 26167880 |
| Pubmed | NACA BCOR SQSTM1 CAMSAP1 PRRC2A PRRC2B MAGED1 NSD1 NUP214 RAB3GAP1 | 1.79e-06 | 242 | 203 | 10 | 34011540 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 METTL3 COPB2 RXRB PARP1 NF1 MED12L TLN2 STK24 PLRG1 SEC31B TLN1 YLPM1 SRRM2 SNX2 | 1.95e-06 | 582 | 203 | 15 | 20467437 |
| Pubmed | NOLC1 BACH1 MAML1 BCOR PARP1 ZBTB40 KDM6A PRRC2A PLRG1 PRRC2B HYOU1 PALB2 SLC3A2 MAP7D1 ARID2 TLN1 EHMT1 PAK2 SRRM2 ZMYM4 TP53BP1 | 2.27e-06 | 1103 | 203 | 21 | 34189442 | |
| Pubmed | 2.74e-06 | 104 | 203 | 7 | 9205841 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BRIP1 BCOR MYSM1 DDX10 CDCA2 PARP1 ZBTB40 ADNP2 NSD1 ARID2 EHMT1 SENP6 SNAPC4 PRDM15 ZMYM4 | 3.31e-06 | 608 | 203 | 15 | 36089195 |
| Pubmed | GAK GAP43 MAP2 COPB2 PARP1 NF1 TLN2 PRRC2A ARHGAP21 PRRC2B HYOU1 EPB41L4B PCLO BCAS1 MADD SLC3A2 MISP MAP7D1 INF2 KIAA1217 TLN1 PDE4DIP PLCH1 SNX2 | 3.70e-06 | 1431 | 203 | 24 | 37142655 | |
| Pubmed | BRIP1 NACA TLN2 TACC1 CAMSAP1 ARHGAP21 CAST CEP43 SLC1A5 MISP ARID2 SRRM2 TP53BP1 | 4.70e-06 | 472 | 203 | 13 | 38943005 | |
| Pubmed | NACA UBE4A NF1 PRRC2A PRRC2B CDC42BPG TANK MAGED1 HYOU1 TXLNB | 7.15e-06 | 283 | 203 | 10 | 21903422 | |
| Pubmed | NOLC1 COPB2 TASOR2 DDX10 NF1 PRRC2A PRRC2B HYOU1 NSD1 NUP214 TLN1 YLPM1 SLTM SRRM2 TP53BP1 | 7.77e-06 | 653 | 203 | 15 | 22586326 | |
| Pubmed | SLC30A1 COBL ARHGAP21 STIM2 EPB41L4B PPFIBP1 SLC3A2 JPH1 INF2 KIAA1217 PLCH1 SLC29A1 | 7.79e-06 | 421 | 203 | 12 | 36976175 | |
| Pubmed | GAK ABL1 MAP2 COPB2 RXRB CDCA2 KATNIP PRRC2B VTN ADNP2 NSD1 TACC2 RAB3GAP1 PDE4DIP LPIN2 PPIP5K1 PNPLA7 PLCH1 ZMYM4 | 7.91e-06 | 1006 | 203 | 19 | 15226823 | |
| Pubmed | 9.15e-06 | 23 | 203 | 4 | 20301575 | ||
| Pubmed | ANKS6 TRPM7 TACC1 STIM2 PPFIBP1 MADD SLC3A2 JPH1 SLC7A2 VPS13D INF2 SLC29A1 SNX2 | 9.47e-06 | 504 | 203 | 13 | 34432599 | |
| Pubmed | NBPF12 CSMD3 PARP1 STK24 SMG6 PALB2 NBPF1 JPH1 CMTM1 KIAA1217 SRRM2 ZMYM4 ALPK2 | 1.14e-05 | 513 | 203 | 13 | 25798074 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MAML1 HAUS8 COBL CAMSAP1 ARHGAP21 PRRC2B ANKS1A AVEN TANK HYOU1 PPFIBP1 CAST CRKL KIAA1217 TLN1 SNX2 NIN | 1.22e-05 | 853 | 203 | 17 | 28718761 |
| Pubmed | GAK NACA UBE4A SQSTM1 TACC1 ANKS1A SLC1A5 CRKL SLC3A2 RAB3GAP1 TLN1 SNX2 | 1.48e-05 | 449 | 203 | 12 | 31732153 | |
| Pubmed | NOLC1 NACA MAML1 ADGRV1 BCOR MED12L SMG6 ANKS1A VPS50 EHMT1 SENP6 ZMYM4 NIN | 1.58e-05 | 529 | 203 | 13 | 14621295 | |
| Pubmed | Gene mapping of the three subunits of the high affinity FcR for IgE to mouse chromosomes 1 and 19. | 2.28e-05 | 10 | 203 | 3 | 2531187 | |
| Pubmed | 2.28e-05 | 10 | 203 | 3 | 30348677 | ||
| Pubmed | GAK BRIP1 PHF19 PARP1 BASP1 SQSTM1 ARHGAP21 AVEN HYOU1 PALB2 SLC7A2 ATP2C1 ARID2 TLN1 | 2.42e-05 | 634 | 203 | 14 | 34591612 | |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 2.50e-05 | 59 | 203 | 5 | 16083285 | |
| Pubmed | MAML1 BCOR PLEKHH1 NF1 KDM6A PRRC2B VTN REV3L SEC31B SLC3A2 RAB3GAP1 ARID2 EHMT1 CSPP1 | 2.60e-05 | 638 | 203 | 14 | 31182584 | |
| Pubmed | 2.94e-05 | 101 | 203 | 6 | 10997877 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 2.94e-05 | 101 | 203 | 6 | 24613305 | |
| Pubmed | 3.13e-05 | 31 | 203 | 4 | 19690177 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 3.13e-05 | 31 | 203 | 4 | 18195088 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.29e-05 | 208 | 203 | 8 | 33230847 | |
| Pubmed | Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families. | 3.39e-05 | 2 | 203 | 2 | 22692731 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 16867995 | ||
| Pubmed | Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK. | 3.39e-05 | 2 | 203 | 2 | 11121037 | |
| Pubmed | Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. | 3.39e-05 | 2 | 203 | 2 | 15361874 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 37482682 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 9150186 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 10871284 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 30718900 | ||
| Pubmed | Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway. | 3.39e-05 | 2 | 203 | 2 | 31789418 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 22179830 | ||
| Pubmed | SLC3A2 and SLC7A2 Mediate the Exogenous Putrescine-Induced Adipocyte Differentiation. | 3.39e-05 | 2 | 203 | 2 | 36572564 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 3.39e-05 | 2 | 203 | 2 | 26523364 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23852372 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 10435627 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 9710592 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 11698424 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 12384580 | ||
| Pubmed | Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells. | 3.39e-05 | 2 | 203 | 2 | 18059481 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 33267838 | ||
| Pubmed | Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. | 3.39e-05 | 2 | 203 | 2 | 18614052 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 27466483 | ||
| Pubmed | Retinoid x receptor gamma control of affective behaviors involves dopaminergic signaling in mice. | 3.39e-05 | 2 | 203 | 2 | 20620876 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 22306379 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 20595277 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 27074847 | ||
| Pubmed | FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. | 3.39e-05 | 2 | 203 | 2 | 38521768 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 NACA COPB2 DDX10 CDCA2 UBE4A PARP1 NF1 SQSTM1 TLN2 PLRG1 HYOU1 PCLO NUP214 SLC1A5 CRKL SLC3A2 TLN1 SLTM EHMT1 SRRM2 SNX2 | 3.41e-05 | 1425 | 203 | 22 | 30948266 |
| Pubmed | 3.66e-05 | 105 | 203 | 6 | 9628581 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MAP2 BACH1 COBL PLRG1 ARHGAP21 VPS50 NUP214 VPS13D MAP7D1 ARID2 RP1 CSPP1 | 3.98e-05 | 497 | 203 | 12 | 36774506 |
| Pubmed | NOLC1 PPRC1 ADAM7 DZIP1L TASOR2 CDCA2 PARP1 ZBED4 ARHGAP21 PRRC2B STIM2 HYOU1 PCDHGA6 PCDHGA3 PCDHGA1 PCLO PALB2 SLC3A2 MAP7D1 LATS2 YLPM1 PLCH1 | 4.06e-05 | 1442 | 203 | 22 | 35575683 | |
| Pubmed | 4.10e-05 | 347 | 203 | 10 | 17114649 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | MAML1 BCOR KDM6A PRRC2B HYOU1 NUP214 ARID2 EHMT1 ZFHX3 ZMYM4 | 4.52e-05 | 351 | 203 | 10 | 38297188 |
| Interaction | CEP135 interactions | TRPM7 HAUS8 DACT1 SQSTM1 CAMSAP1 STK24 ARHGAP21 PRRC2B TANK MAGED1 CEP43 TXLNB CSPP1 ZMYM4 NIN | 1.03e-07 | 272 | 201 | 15 | int:CEP135 |
| Interaction | TOP3B interactions | ANKS6 ABL1 PPRC1 MAML1 DACT1 CYREN ZBED4 COBL TLN2 UNKL DENND5A CAMSAP1 PRRC2A ARHGAP21 PRRC2B SMG6 EPN3 HYOU1 MEX3D NSD1 NUP214 REV3L FAAP100 ATP13A2 SLC1A5 MADD CRKL NBPF1 HIVEP3 LATS2 ZNF827 INF2 TLN1 EHMT1 MAPKBP1 SNAPC4 TP53BP1 | 1.51e-07 | 1470 | 201 | 37 | int:TOP3B |
| Interaction | YWHAH interactions | NOLC1 ABL1 MAP2 TRPM7 CDCA2 HAUS8 NF1 BASP1 SQSTM1 COBL CAMSAP1 ARHGAP21 ANKS1A CDC42BPG STIM2 PPFIBP1 MEX3D SLC1A5 MADD VPS13D MAP7D1 LATS2 KIAA1217 PAK2 PLCH1 CDC25A SRRM2 CSPP1 SNX2 OTOG NIN | 1.66e-07 | 1102 | 201 | 31 | int:YWHAH |
| Interaction | SYNE3 interactions | GAK TRPM7 HAUS8 SQSTM1 TACC1 CAMSAP1 ARHGAP21 PRRC2B STIM2 HYOU1 NUP214 CEP43 PALB2 JPH1 LATS2 KIAA1217 CSPP1 NIN | 5.38e-07 | 444 | 201 | 18 | int:SYNE3 |
| Interaction | MAPRE3 interactions | MAP2 HAUS8 COBL TACC1 CAMSAP1 PRRC2A ARHGAP21 STIM2 TACC2 CEP43 MAP7D1 KIAA1217 PDE4DIP | 5.66e-07 | 230 | 201 | 13 | int:MAPRE3 |
| Interaction | YWHAZ interactions | NOLC1 ABL1 MAP2 TRPM7 BCKDHA BCOR NF1 SQSTM1 AK5 KATNIP PRR14L CAMSAP1 PRRC2A ARHGAP21 ANKS1A CDC42BPG STIM2 PPFIBP1 TACC2 MADD SLC3A1 VPS13D MAP7D1 LATS2 LPIN2 PAK2 PLCH1 CDC25A TP53BP1 OTOG IL9R NIN | 2.61e-06 | 1319 | 201 | 32 | int:YWHAZ |
| Interaction | GSK3A interactions | MAP2 PARP1 SQSTM1 COBL CRYBG1 CAMSAP1 PLRG1 ARHGAP21 ANKS1A TANK PPFIBP1 CEP43 MISP VPS13D SRRM2 SNX2 NIN | 4.40e-06 | 464 | 201 | 17 | int:GSK3A |
| Interaction | NAA40 interactions | NOLC1 GAK NACA BCOR DDX10 PARP1 TACC1 PRR14L CAMSAP1 PRRC2A PLRG1 ARHGAP21 PRRC2B ANKS1A CAST TACC2 NUP214 SLC1A5 SLC3A2 ARID2 KIAA1217 TLN1 YLPM1 PAK2 SENP6 TP53BP1 | 5.11e-06 | 978 | 201 | 26 | int:NAA40 |
| Interaction | KCNA3 interactions | NACA COPB2 SLC30A1 PARP1 COBL TLN2 CAMSAP1 PRRC2A ARHGAP21 ANKS1A STIM2 HYOU1 PPFIBP1 NUP214 SLC1A5 CRKL SLC3A2 JPH1 TLN1 PAK2 SENP6 RP1 PLCH1 OTOG | 6.71e-06 | 871 | 201 | 24 | int:KCNA3 |
| Interaction | DEUP1 interactions | 1.18e-05 | 77 | 201 | 7 | int:DEUP1 | |
| Interaction | GJD3 interactions | TRPM7 SLC30A1 BASP1 SQSTM1 TACC1 STIM2 EPB41L4B PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 RAB3GAP1 ATP2C1 INF2 SLC29A1 | 1.37e-05 | 454 | 201 | 16 | int:GJD3 |
| Interaction | RAB3B interactions | SLC30A1 BASP1 TACC1 STIM2 SLC1A5 MADD SLC3A2 JPH1 SLC7A2 VPS13D INF2 SLC29A1 NIN | 1.50e-05 | 310 | 201 | 13 | int:RAB3B |
| Interaction | MAPRE1 interactions | MAP2 COBL TACC1 CAMSAP1 PRRC2A ARHGAP21 PRRC2B TACC2 NUP214 CEP43 MISP MAP7D1 KIAA1217 PDE4DIP SRRM2 CSPP1 NIN | 1.67e-05 | 514 | 201 | 17 | int:MAPRE1 |
| Interaction | CXADR interactions | ANKS6 COPB2 SLC30A1 BASP1 TACC1 STIM2 EPB41L4B PPFIBP1 SLC1A5 SLC3A2 JPH1 LATS2 INF2 PLCH1 | 2.15e-05 | 369 | 201 | 14 | int:CXADR |
| Interaction | B3GAT1 interactions | TRPM7 SQSTM1 TACC1 STIM2 PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 RAB3GAP1 ATP2C1 INF2 SLC29A1 SNX2 | 2.72e-05 | 377 | 201 | 14 | int:B3GAT1 |
| Interaction | RAB9A interactions | TRPM7 SLC30A1 BASP1 TACC1 STIM2 TANK HYOU1 PPFIBP1 VPS50 ATP13A2 SLC1A5 SLC3A2 JPH1 RAB3GAP1 VPS13D INF2 SLC29A1 SNX2 | 3.06e-05 | 595 | 201 | 18 | int:RAB9A |
| Interaction | H3C1 interactions | BRIP1 PHF19 NACA MYSM1 DDX10 CDCA2 PARP1 BASP1 PCDH11X PRR14L CAMSAP1 KDM6A CAST NSD1 PALB2 MAP7D1 ARID2 EHMT1 SENP6 ZFHX3 ZMYM4 TP53BP1 PDZD2 | 3.53e-05 | 901 | 201 | 23 | int:H3C1 |
| Interaction | STX6 interactions | GAK COPB2 SLC30A1 BASP1 TACC1 ARHGAP21 STIM2 PPFIBP1 VPS50 SLC3A2 JPH1 SLC7A2 INF2 SLC29A1 SNX2 | 4.62e-05 | 448 | 201 | 15 | int:STX6 |
| Interaction | RAC3 interactions | TRPM7 SLC30A1 NF1 BASP1 CRYBG1 TACC1 ARHGAP21 ANKS1A STIM2 PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 KIAA1217 PAK2 SLC29A1 DISP1 | 5.11e-05 | 619 | 201 | 18 | int:RAC3 |
| Interaction | ARL4C interactions | 6.74e-05 | 136 | 201 | 8 | int:ARL4C | |
| Interaction | DIRAS3 interactions | TRPM7 SLC30A1 BASP1 ARHGAP21 PPFIBP1 SLC1A5 PALB2 SLC3A2 SLC7A2 PLCH1 SLC29A1 | 6.78e-05 | 262 | 201 | 11 | int:DIRAS3 |
| Interaction | GJA1 interactions | TRPM7 CNST SLC30A1 PARP1 BASP1 SQSTM1 TACC1 ARHGAP21 STIM2 EPB41L4B PPFIBP1 SLC1A5 SLC3A2 JPH1 INF2 KIAA1217 PLCH1 | 8.04e-05 | 583 | 201 | 17 | int:GJA1 |
| Interaction | CDK8 interactions | BRIP1 MAML1 BCKDHA MYSM1 DDX10 PARP1 MED12L EHMT1 ZMYM4 TP53BP1 | 8.15e-05 | 222 | 201 | 10 | int:CDK8 |
| Interaction | LILRA1 interactions | 9.90e-05 | 2 | 201 | 2 | int:LILRA1 | |
| Interaction | STX4 interactions | COPB2 BASP1 TACC1 TACR1 STIM2 PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 RAB3GAP1 TXLNB INF2 SLC29A1 | 1.06e-04 | 428 | 201 | 14 | int:STX4 |
| Interaction | LYN interactions | SLC30A1 NF1 PTPRC FCGR2A BASP1 ARHGAP21 EPB41L4B PPFIBP1 CEP43 SLC1A5 CRKL SLC3A2 JPH1 SLC7A2 KIAA1217 PAK2 PLCH1 SRRM2 SLC29A1 | 1.14e-04 | 720 | 201 | 19 | int:LYN |
| Interaction | PHLPP1 interactions | NACA SLC30A1 CDCA2 BASP1 SQSTM1 PHLPP1 NUP214 SLC1A5 SLC3A2 MISP KIAA1217 TLN1 | 1.36e-04 | 333 | 201 | 12 | int:PHLPP1 |
| Interaction | DCTN1 interactions | DCDC1 MAP2 NACA HAUS8 NF1 CAMSAP1 STK24 ARHGAP21 HYOU1 VPS50 MISP MAP7D1 KIAA1217 SNX2 NIN | 1.47e-04 | 497 | 201 | 15 | int:DCTN1 |
| Interaction | AR interactions | GAK ABL1 MAML1 BCOR MYSM1 CDCA2 PARP1 SQSTM1 MED12L DENND5A KDM6A PLRG1 PRRC2B CDC42BPG MAGED1 NSD1 LATS2 ARID2 KIAA1217 YLPM1 ZFHX3 CDC25A ZMYM4 | 1.50e-04 | 992 | 201 | 23 | int:AR |
| Interaction | ATG9A interactions | GAK ANKS6 AVL9 PARP1 NF1 SQSTM1 AP3M2 COBL DENND5A TBC1D30 VPS50 TACC2 SLC3A2 SNX2 | 1.59e-04 | 445 | 201 | 14 | int:ATG9A |
| Interaction | GSK3B interactions | NACA COPB2 PARP1 BASP1 SQSTM1 PHLPP1 COBL CAMSAP1 ARHGAP21 ANKS1A TANK GPR39 PPFIBP1 CAST CEP43 SLC3A2 MISP VPS13D PAK2 SNX2 NIN | 1.66e-04 | 868 | 201 | 21 | int:GSK3B |
| Interaction | KLF15 interactions | MAML1 BCOR SQSTM1 KDM6A PRRC2A PRRC2B ANKS1A MAP7D1 ARID2 EHMT1 ZMYM4 | 1.66e-04 | 290 | 201 | 11 | int:KLF15 |
| Interaction | NUP50 interactions | BRIP1 NACA BCOR MYSM1 CDCA2 NSD1 NUP214 ARID2 PAK2 SENP6 SRRM2 TP53BP1 | 1.70e-04 | 341 | 201 | 12 | int:NUP50 |
| Interaction | SOX7 interactions | 1.70e-04 | 82 | 201 | 6 | int:SOX7 | |
| Interaction | ZFPL1 interactions | COPB2 SLC30A1 BASP1 TACC1 ARHGAP21 PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 VPS13D KASH5 PLCH1 SLC29A1 | 1.71e-04 | 448 | 201 | 14 | int:ZFPL1 |
| Interaction | ARL14 interactions | 1.93e-04 | 119 | 201 | 7 | int:ARL14 | |
| Interaction | RAB35 interactions | TRPM7 SLC30A1 BASP1 TACC1 ARHGAP21 STIM2 EPB41L4B PPFIBP1 SLC1A5 SLC3A2 JPH1 SLC7A2 INF2 PLCH1 SLC29A1 SNX2 | 2.14e-04 | 573 | 201 | 16 | int:RAB35 |
| Interaction | NINL interactions | NACA MAML1 HAUS8 YJU2B COBL CAMSAP1 ARHGAP21 PRRC2B CEP43 CRKL LATS2 KIAA1217 ZFHX3 CSPP1 | 2.14e-04 | 458 | 201 | 14 | int:NINL |
| Cytoband | 15q15-q21 | 1.15e-04 | 4 | 202 | 2 | 15q15-q21 | |
| Cytoband | 5q35 | 1.39e-04 | 23 | 202 | 3 | 5q35 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.87e-04 | 20 | 131 | 3 | 548 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.68e-04 | 50 | 131 | 4 | 1293 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 7.67e-04 | 6 | 131 | 2 | 1181 | |
| GeneFamily | Clustered protocadherins | 1.20e-03 | 64 | 131 | 4 | 20 | |
| GeneFamily | Doublecortin superfamily | 2.26e-03 | 10 | 131 | 2 | 1369 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | RXRB CDCA2 PARP1 BASP1 DENND5A ARHGAP21 ANKS1A ATP13A2 LPIN2 EHMT1 CIPC TP53BP1 | 4.63e-08 | 200 | 199 | 12 | M304 |
| Coexpression | GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP | ABL1 SLC30A1 ZBED4 SQSTM1 PHLPP1 KATNIP TACC1 ANKS1A MADD MAP7D1 | 2.06e-06 | 190 | 199 | 10 | M3289 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | ANKS6 HMGCS2 OLFML2A TLN2 TACC1 EPN3 TBC1D30 EPB41L4B GPR39 CAST XK TACC2 BCAS1 LATS2 ZNF827 KIAA1217 PDZD2 | 2.52e-06 | 583 | 199 | 17 | M17454 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | PDE4C GAP43 MAP2 ZC3H8 CSMD3 DACT1 KIAA1549L BASP1 PCDH11X TLN2 PRRC2B STIM2 PPFIBP1 PCLO XK REV3L SEC31B JPH1 HIVEP3 OTP CACNG8 PDE4DIP ZFHX3 | 1.25e-05 | 1106 | 199 | 23 | M39071 |
| Coexpression | HOXA9_DN.V1_DN | 1.57e-05 | 190 | 199 | 9 | M2848 | |
| Coexpression | IBRAHIM_NRF1_UP | NOLC1 NACA DDX10 CYREN UNKL PLRG1 HYOU1 TBC1D30 ADNP2 HTRA3 SLC1A5 MAP7D1 SLTM | 2.14e-05 | 420 | 199 | 13 | M42509 |
| Coexpression | GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN | HAUS8 CDC42BPG MAGED1 PPFIBP1 FANCM ATP13A2 C4orf54 LPIN2 PPIP5K1 | 2.18e-05 | 198 | 199 | 9 | M6190 |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | BCOR SLC30A1 TAF4B ARHGAP21 MAGED1 SLC1A5 MAP7D1 KIAA1217 PPIP5K1 | 2.36e-05 | 200 | 199 | 9 | M6533 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | NOLC1 CAAP1 ANKS6 ABL1 NACA BCOR ZNF804A RXRG DDX10 CDCA2 PARP1 COBL STK24 PRRC2B ANKS1A STIM2 TANK WDR27 SLC7A2 KIAA1217 PDE4DIP | 3.01e-05 | 1009 | 199 | 21 | M157 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 4.80e-05 | 219 | 199 | 9 | M41199 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | MAML1 SQSTM1 TACC1 PPFIBP1 CEP43 VPS13D LATS2 KIAA1217 PDZD2 | 6.33e-05 | 227 | 199 | 9 | M18441 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.06e-07 | 188 | 202 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 195 | 202 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.13e-06 | 170 | 202 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 184 | 202 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-06 | 188 | 202 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-06 | 191 | 202 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.70e-06 | 191 | 202 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 193 | 202 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 2.96e-06 | 136 | 202 | 7 | e272d11bb52f890f6681cc9384aeac27976ec650 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.11e-06 | 137 | 202 | 7 | 12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 3.59e-06 | 140 | 202 | 7 | cade44740dd3acca7789591aa5a7935d48d5cbee | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 200 | 202 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.19e-05 | 168 | 202 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 176 | 202 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.61e-05 | 176 | 202 | 7 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.92e-05 | 181 | 202 | 7 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.29e-05 | 186 | 202 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.29e-05 | 186 | 202 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 186 | 202 | 7 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 187 | 202 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.54e-05 | 189 | 202 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.72e-05 | 191 | 202 | 7 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.72e-05 | 191 | 202 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-05 | 191 | 202 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.81e-05 | 192 | 202 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 202 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 202 | 7 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.81e-05 | 192 | 202 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.90e-05 | 193 | 202 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 202 | 7 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 195 | 202 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.10e-05 | 195 | 202 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.20e-05 | 196 | 202 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 3.31e-05 | 197 | 202 | 7 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 3.31e-05 | 197 | 202 | 7 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 202 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 202 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 202 | 7 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.53e-05 | 199 | 202 | 7 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.53e-05 | 199 | 202 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.53e-05 | 199 | 202 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 200 | 202 | 7 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Suprabasal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 200 | 202 | 7 | 924eacea513dde8e3bd805a335bc4285647b800d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-05 | 200 | 202 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 200 | 202 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.83e-05 | 137 | 202 | 6 | 9bfdbc102cdd861996b3c4eac35b606be8af97eb | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 158 | 202 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 8.77e-05 | 159 | 202 | 6 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-05 | 161 | 202 | 6 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-05 | 161 | 202 | 6 | 9cfbbcd38ec2e75376bbc26001964b6991ad0e21 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 163 | 202 | 6 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 164 | 202 | 6 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 165 | 202 | 6 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 173 | 202 | 6 | 0a0127bcb1d7b2b6125faef576dd843055095528 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 173 | 202 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 174 | 202 | 6 | fde40c5d51f5380088360dc5a583eb04e518deb6 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.44e-04 | 174 | 202 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 175 | 202 | 6 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 175 | 202 | 6 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 176 | 202 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 178 | 202 | 6 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 178 | 202 | 6 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.63e-04 | 178 | 202 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.63e-04 | 178 | 202 | 6 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 178 | 202 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 179 | 202 | 6 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.68e-04 | 179 | 202 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 179 | 202 | 6 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 180 | 202 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 181 | 202 | 6 | 71e55acd1d8e4307e56534c74a50e7be4d1dda0d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 181 | 202 | 6 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 181 | 202 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 182 | 202 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 182 | 202 | 6 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-04 | 182 | 202 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 182 | 202 | 6 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 182 | 202 | 6 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 183 | 202 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.95e-04 | 184 | 202 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.95e-04 | 184 | 202 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-04 | 185 | 202 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-04 | 185 | 202 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.00e-04 | 185 | 202 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-04 | 185 | 202 | 6 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 185 | 202 | 6 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-04 | 186 | 202 | 6 | b9e0a819cd0b250f077b26eba99e6986d68d647b | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.06e-04 | 186 | 202 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-04 | 187 | 202 | 6 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-04 | 187 | 202 | 6 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 188 | 202 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 2.19e-04 | 188 | 202 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.19e-04 | 188 | 202 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 189 | 202 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 189 | 202 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.25e-04 | 189 | 202 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 189 | 202 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 189 | 202 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 189 | 202 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | METTL3 NF1 AP3M2 COBL UNKL KDM6A FAAP100 HIVEP3 YLPM1 SENP6 SNAPC4 | 1.31e-06 | 197 | 198 | 11 | 5815_DN |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | ZBED4 AP3M2 COBL CAMSAP1 TACC2 FAAP100 ATP2C1 PDE4DIP YLPM1 SRRM2 SLC29A1 | 1.51e-06 | 200 | 198 | 11 | 7410_DN |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; PC3; HT_HG-U133A | GAK AVL9 FAM50B UNKL TBC1D30 ATP13A2 MADD VPS13D SRRM2 ZMYM4 | 8.87e-06 | 196 | 198 | 10 | 5877_DN |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | SYNC TRIM66 YJU2B TLN2 KATNIP KDM6A PPFIBP1 ATP13A2 SLC3A1 PLCH1 | 9.70e-06 | 198 | 198 | 10 | 3560_DN |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | OLFML2A NF1 KIAA1549L ZBTB40 COBL TLN2 UNKL CAST VPS13D ZFHX3 | 9.70e-06 | 198 | 198 | 10 | 2090_UP |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | PDE4C GAP43 AVL9 NF1 UNKL PRRC2B FAAP100 ATP13A2 PDE4DIP SNAPC4 | 9.70e-06 | 198 | 198 | 10 | 6356_UP |
| Drug | geldanamycin | BCOR ZNF518A CDCA2 PARP1 NF1 PRR14L KDM6A VPS50 FANCM PDE4DIP EHMT1 SRRM2 TP53BP1 | 2.38e-05 | 371 | 198 | 13 | ctd:C001277 |
| Drug | lomustine; Up 200; 100uM; MCF7; HT_HG-U133A | 3.65e-05 | 185 | 198 | 9 | 7045_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 190 | 198 | 9 | 3927_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.68e-05 | 191 | 198 | 9 | 2634_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 3321_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 198 | 9 | 3539_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 5.28e-05 | 194 | 198 | 9 | 2009_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | AVL9 FAM50B OLFML2A PHLPP1 TANK CEP43 RAB3GAP1 YLPM1 MAPKBP1 | 5.50e-05 | 195 | 198 | 9 | 6913_UP |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; HL60; HG-U133A | 5.50e-05 | 195 | 198 | 9 | 1762_DN | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 5111_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 5318_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | KDM6A PRRC2B TBC1D30 RAB3GAP1 VPS13D ATP2C1 MAPKBP1 CSPP1 SNX2 | 5.72e-05 | 196 | 198 | 9 | 1861_DN |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.72e-05 | 196 | 198 | 9 | 5072_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 2837_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 6727_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 6341_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; HL60; HG-U133A | 6.19e-05 | 198 | 198 | 9 | 2002_UP | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 7243_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 1527_UP | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 5824_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.68e-05 | 200 | 198 | 9 | 7015_DN | |
| Disease | Bone marrow hypocellularity | 5.26e-06 | 18 | 195 | 4 | C1855710 | |
| Disease | Pancytopenia | 2.47e-05 | 26 | 195 | 4 | C0030312 | |
| Disease | glutamate measurement | 3.86e-05 | 29 | 195 | 4 | EFO_0010487 | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate E (implicated_via_orthology) | 4.35e-05 | 2 | 195 | 2 | DOID:0110205 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | XIRP1 BRIP1 ABL1 RXRB DDX10 PARP1 NF1 PTPRC ADGRF4 TREML1 PRRC2A TANK TACC2 NUP214 PALB2 LIPE EHMT1 LONRF3 TP53BP1 | 1.00e-04 | 1074 | 195 | 19 | C0006142 |
| Disease | osteoarthritis | 1.22e-04 | 222 | 195 | 8 | MONDO_0005178 | |
| Disease | forehead morphology measurement | 1.22e-04 | 15 | 195 | 3 | EFO_0007844 | |
| Disease | serum gamma-glutamyl transferase measurement | PDE4C BRIP1 TRPM7 BACH1 CSMD3 ZNF804A UBE4A NF1 PRRC2A ARHGAP21 GPR39 FAAP100 ZNF827 TLN1 RP1 ALPK2 TP53BP1 | 1.30e-04 | 914 | 195 | 17 | EFO_0004532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VARDGPLSQTSSKPD | 371 | O75410 | |
| QENGLGSLSPSDLNK | 876 | Q86US8 | |
| GNAKASPPLQDSASQ | 191 | O14867 | |
| PRDSKGLAAAEPTAN | 6 | Q15758 | |
| NSPLIGSFQDSKLPE | 1651 | Q7Z407 | |
| GDSAVANKQPSPQLS | 286 | Q86TB3 | |
| NKPASKDSRGIADPN | 736 | Q9H2U9 | |
| PNNGDVSSKDTDIPL | 811 | Q9H5V8 | |
| RSTAQQELDGKPASP | 846 | P35606 | |
| PSSKQNGTKEPDALD | 461 | Q9H201 | |
| LLLASADSQAAAPPK | 26 | P12318 | |
| AAENASLGPTNGSKL | 676 | Q8IZF3 | |
| ASFQQGSQASPDLKP | 6216 | Q8WXG9 | |
| DSSLPPSNSGKIQSE | 1301 | Q68CP9 | |
| APGASQPSALDQSKR | 551 | Q92625 | |
| LGLAESSPNEPKAAT | 306 | Q9H8G2 | |
| RPSGASSSQTPNDKE | 16 | Q8NBA8 | |
| PASDKQSPLNINGAS | 171 | Q6W2J9 | |
| SPAPNANADGTKTSR | 571 | Q6W2J9 | |
| SEESLKPSDNEQGLP | 1271 | Q6W2J9 | |
| KNISASAREPPSENG | 226 | P52569 | |
| PQGQLDTSESKPDSF | 576 | Q5T5Y3 | |
| QSPSQHGKDPASLLA | 861 | Q5T5Y3 | |
| KSTESDAGSALLQPP | 1241 | Q96F81 | |
| SKVTAPQPAATNGDL | 196 | P98194 | |
| APKDSSSDLQAQPGF | 941 | Q6IQ32 | |
| EKPLDGTTSTDNNNP | 421 | Q15042 | |
| DPLQTSGKAAAPSED | 2511 | Q96L73 | |
| SLPAKQAPQGSRDSS | 456 | Q14978 | |
| APAAVNSSASADKPL | 376 | P09874 | |
| APTANTASTEGLPAK | 861 | Q6DT37 | |
| AGSSLPPNSDRNKSQ | 791 | Q9Y5F3 | |
| TLANSLDPNGEGPKA | 76 | Q8N6L0 | |
| QAGASKPDENPTINL | 361 | P53677 | |
| AATPGRKPQLSEDES | 706 | Q8IYY4 | |
| EDSGKQALAPGLSPS | 111 | Q9BWK5 | |
| SAEGPSANTEAPLKA | 1101 | Q9C0D6 | |
| LGQSDKPSGADALQS | 161 | Q92585 | |
| GSNPSESFPLSLNKE | 201 | Q92585 | |
| LSLEQANKGAPHSSP | 201 | Q8IVT2 | |
| SASNLGLKQLPEPSD | 816 | M0R2J8 | |
| GSLEPSAKPNDSDLT | 676 | Q9Y5G7 | |
| LSLESLEPNSGAKPA | 426 | O43194 | |
| LEPNSGAKPANSAAE | 431 | O43194 | |
| SADSTPDVNQSPRGK | 146 | Q8WXG6 | |
| NENKSANPGSPLDLL | 386 | Q86YW9 | |
| SLNANDLANSRPKTP | 166 | Q9Y5V3 | |
| SEKPADPLSASLGLQ | 66 | A8MVJ9 | |
| PNKEAAAGSSDLDPS | 321 | Q9Y6K8 | |
| PPAGSKSDSNFSNLI | 491 | Q8NE63 | |
| GLPAGPNSDTSLDAK | 36 | Q9NRM7 | |
| LDAQGFSDLEKSPSP | 366 | Q86W92 | |
| PPAETLADAKLSSQG | 661 | O60303 | |
| AAQPLLAGEKESPSS | 1241 | Q2LD37 | |
| GSSKAPLPAAAEAQL | 36 | Q8IYD8 | |
| DSKSPGLLSSDNPQL | 766 | O15550 | |
| KSELAIPKNPASNDS | 611 | Q9HDC5 | |
| APAAQETKSDGAPAS | 156 | P80723 | |
| SQDAAPGSPLDKLVS | 426 | P54868 | |
| SLNLGSITDAPKSQP | 906 | Q9Y6V0 | |
| PLQTKADANRTAPSG | 131 | O43660 | |
| AANLTDSAEAPKGSP | 1056 | O15018 | |
| SSNQLPPAEDTGQKL | 191 | Q08493 | |
| DSSRPNVAPDGLSLK | 1141 | Q1MSJ5 | |
| GNLSPSVEKESQPDN | 501 | Q8IXT1 | |
| LDSGASENSRKPPSA | 576 | Q86XN8 | |
| SQAPQKLDASAAAAP | 441 | P35658 | |
| PPNGLTSAADAIKSQ | 446 | Q6ZVL6 | |
| LLAADAGKPPLNQSA | 436 | Q9BZA7 | |
| GSVSAPNLPTAEDNL | 111 | P46109 | |
| KALVTSRSAPGDPNA | 256 | Q0VG06 | |
| GTAPPDLDLSAINDK | 96 | Q9BT25 | |
| PEPKSQRDSALGAAA | 6 | Q05925 | |
| ALLTPDEPDKSQGQD | 671 | Q3BBV0 | |
| EKLGPQDSDPTEANL | 16 | Q27J81 | |
| PSLAFPKLSEGSSDQ | 1301 | Q6ZV29 | |
| GKSSDVSSLNDPQPS | 331 | Q9UHF4 | |
| SGLNSSASEPAKEPA | 196 | Q86U44 | |
| IPKATPELGSSENSA | 1016 | Q9BX63 | |
| GSLEPSAKPNDSDLT | 676 | Q9Y5H0 | |
| KGDSNLLQQAPPNTD | 801 | Q9Y5H0 | |
| KVSSPAGPTEDNDLS | 486 | Q86YC2 | |
| ATNGTPELQNPEKLS | 456 | Q13177 | |
| KSQNPDPFADLGDLS | 1076 | O14976 | |
| SPTAVNGVKDPDQAA | 796 | Q9NQ11 | |
| PAPGTLAKEAAASNT | 401 | Q8WXS5 | |
| KNGTRAEPPLNASAS | 921 | Q9Y4L1 | |
| AEPPLNASASDQGEK | 926 | Q9Y4L1 | |
| NASASDQGEKVIPPA | 931 | Q9Y4L1 | |
| ELKASNPDFPEVSSG | 371 | P83110 | |
| SSNSEDAFSPGIKQP | 111 | Q9BX69 | |
| KESAQLSGASPKESP | 476 | Q9NYF0 | |
| QAGSLASLSDAPPLK | 276 | O95684 | |
| NNLTELKSFGSPPDA | 3146 | Q9UFH2 | |
| RDSQKPTSPLQSAGD | 266 | Q9NQS1 | |
| SPTLPAVKQAGDDSQ | 366 | Q2WGN9 | |
| GSDQTNLFPKDSVPS | 351 | Q8NBF6 | |
| DQDLAGTPDLGPQKS | 441 | O75128 | |
| PQAEGSLAKATTAPA | 116 | P01880 | |
| KENLLAGPSENDPNL | 51 | P00519 | |
| QLLASSDPPALASKN | 81 | P08195 | |
| SDPPALASKNAEVTG | 86 | P08195 | |
| AAPQDKTSRSALPDA | 501 | Q68DC2 | |
| SPEGQLSLEPKSDSQ | 406 | Q9BSJ5 | |
| PKLQSDVLSTGPASN | 671 | Q6IQ26 | |
| TQAGAPPRDTSQSDK | 551 | P20810 | |
| ANANGSSPEPVKAVE | 736 | Q3KQU3 | |
| KPGAALSQDSEPAVS | 1401 | O60336 | |
| NARKSPLAQDSPSQG | 116 | Q69YH5 | |
| GSQAPSLPNTSEAQK | 601 | Q13206 | |
| PEPSDKTGQNSLTFN | 306 | Q12951 | |
| SQKSTDSPGADAELP | 16 | Q9Y4K1 | |
| LDVSSNKAPANKDPS | 121 | O75363 | |
| APPDEVTNRKSGSNL | 1446 | D6RIA3 | |
| LENKEGPLRSPNSSS | 526 | Q9H329 | |
| GPPLSEDDKLQGAAS | 676 | Q9H9B1 | |
| SPKNLERSAGQSSPA | 536 | Q5VV67 | |
| QPDLTDSDGKSPQAQ | 486 | Q6PJW8 | |
| QEAESTPAAQAKPGA | 151 | Q05469 | |
| GAAETLSPPQNKSDS | 421 | Q8N6C8 | |
| LDSPGPLDSKENLEN | 86 | P30304 | |
| PDVKPGASSSLLSQN | 46 | Q5THK1 | |
| SSLDDKPQFPGASAE | 46 | P12694 | |
| PKVEGRSNSAEPNSA | 321 | Q68BL7 | |
| ASLAVSAKDPDKQPG | 71 | Q5XKR4 | |
| GSLEPSAKPNDSDLT | 676 | Q9Y5H4 | |
| SGNPSPESFLDDKQE | 1056 | Q6ZRI0 | |
| VSDDAIKNQPLPGSN | 1881 | P56715 | |
| EGSLASSQAKAPPDD | 236 | Q5VT03 | |
| GSLAPSQAKARPDDS | 186 | A1L443 | |
| GSLAPSQAKARPDDS | 186 | Q5VZR2 | |
| SLGASSTPSNEPNLK | 226 | Q92750 | |
| SPLPKNSGSLNEAEA | 26 | Q9H7C4 | |
| KLRNSSSPATGEDPE | 81 | Q9BZD2 | |
| SLPAEDISANSNGPK | 46 | O60749 | |
| AGSSPETKEQNSALP | 1216 | Q9UQ35 | |
| GAAETLSPPQNKSDS | 421 | O75019 | |
| LSPPQNKSDSKAGAA | 426 | O75019 | |
| DAAAKATAQPPTETG | 186 | P17677 | |
| PLKNSPSEEVEANSG | 571 | Q8N4C6 | |
| ALLTPDEPDKSQGQD | 671 | Q5TAG4 | |
| PKNLENGALQPSDLD | 346 | Q9Y6E0 | |
| LEQAKSLPPGSQSEA | 586 | P57071 | |
| DGPKATPSSLDLTSN | 371 | P25103 | |
| NEDGSSPTAKQSPLS | 236 | Q8NET5 | |
| TKDTASDSPAGIDNP | 741 | P48764 | |
| LLPSAAASAEPQSKN | 1801 | P48634 | |
| ASKPKDGQDAIAQSP | 276 | Q9NWH9 | |
| AKASSEDAGPSPQTR | 1081 | Q5T5P2 | |
| LEQTPDPGSSTDNLK | 31 | Q07837 | |
| KPFPNQDSDSVVLSG | 371 | Q92844 | |
| LGESPQPKGNDLNSD | 506 | Q9NQW1 | |
| KLDPPSDLQSNISSG | 146 | Q01113 | |
| LSKDAQASAAPAAPL | 56 | Q99808 | |
| SGPSEDPSVNFLKNV | 226 | Q13501 | |
| LFNPDAKGLSNPSEV | 446 | P28702 | |
| APPSAKLAEDSALQG | 216 | Q9C0C6 | |
| AKPESSEAPSGNLKQ | 6 | Q8IZ96 | |
| SEAPSGNLKQPETAA | 11 | Q8IZ96 | |
| QGLKSPQESLSDLGA | 11 | Q96JG6 | |
| SKALNGDDRPSSPVE | 2136 | O60673 | |
| AGNDSKPVQEAPSVA | 701 | Q9P246 | |
| FDTLPPLGQDAASKA | 516 | Q9Y490 | |
| LLAAKALSTDPAAPN | 1316 | Q9Y490 | |
| ALSTDPAAPNLKSQL | 1321 | Q9Y490 | |
| GPSDAARNLPLESTK | 741 | Q5T1R4 | |
| SKPFSRGSQPADVDL | 361 | P21359 | |
| LLPDKGLLPNENSAS | 351 | Q5T6S3 | |
| ANLPSLKSENKGNDP | 61 | Q5JSZ5 | |
| LFNPDAKGLSNPSEV | 376 | P48443 | |
| SSPAPSTGKVEAALN | 361 | Q9GZR1 | |
| SQDKPPSSLALSDAA | 921 | Q68DE3 | |
| IGSSLPQDDDAPKKQ | 2531 | O95359 | |
| APEENKATSKAPQGS | 851 | Q9Y2I9 | |
| KQASLEKPGNDLESP | 111 | A0A1B0GTY4 | |
| FIPSPSLEEQSNDGK | 461 | Q12888 | |
| DVKQDSSNTPNKGLP | 796 | Q6AHZ1 | |
| RQDKPLSPAGSSQEA | 356 | P13994 | |
| AQEDSTFPAQTGPKA | 836 | Q6UXZ4 | |
| LAPSPGALQSKDSVS | 216 | Q9ULM0 | |
| KTAALESNLPGSPNT | 1296 | Q4KWH8 | |
| KAAAAALSGSPPQTE | 6 | Q9H9P5 | |
| SAGPSEQVNSKAPLS | 691 | P49750 | |
| AEPLSGNKEPLADTS | 856 | P49750 | |
| QPDDKKSLQQTSGPA | 346 | P11137 | |
| PKEDNGLPTSFTLNA | 526 | Q17R98 | |
| AKSLSVDPGAPNAKN | 1321 | Q9Y4G6 | |
| VDPGAPNAKNLLAAA | 1326 | Q9Y4G6 | |
| LNASANKLESLPPAT | 991 | O60346 | |
| SQAPAASRKQGLPEA | 1026 | Q5SXM2 | |
| LPNPSSDRKSNSGSD | 596 | Q5VWN6 | |
| TNLPGPLTKANEQAD | 571 | Q9WJR5 | |
| SGQAPQAPTEASLQK | 611 | Q8N3L3 | |
| LDNSDPSLKSGNGIP | 96 | Q14139 | |
| NPSAPQLATATLDGK | 806 | A2RRH5 | |
| GPTQPASLSSQKQDA | 846 | Q5JPB2 | |
| TSNSNGLKLDPADPE | 196 | Q9Y6M5 | |
| NSAPDKSGLPSDRFS | 71 | A0A1B0GXF2 | |
| AGSANPLEPSQDEKS | 146 | Q86YW5 | |
| GSKPALPLDKNTAAA | 581 | O15016 | |
| KPAPQSSENAGTSDL | 691 | Q5T5U3 | |
| AANAKLNPTPGSNAI | 131 | P08575 | |
| LKSDASSDQGPASPE | 916 | Q6BDS2 | |
| PSLTSDLQAQSKGNP | 96 | P04004 | |
| TGSNAQSSEPPKLNA | 1416 | Q702N8 | |
| SKTSPEPGQFLNAED | 426 | P51811 | |
| PSDLNLQPGNSTKES | 1841 | Q96QT4 | |
| GKASDEPDRALQTSP | 951 | Q6PFW1 | |
| GDASTQTDALKLPPS | 921 | Q5VZL5 | |
| SLPGQQEKEASASPD | 716 | Q9NUA8 | |
| ASTEQSGDLKPSPAD | 1336 | Q15911 | |
| ENKNGPETLAPSNTE | 391 | Q7Z570 | |
| PNPALGKTATDSDER | 11 | Q8N5P1 | |
| SSPEKQQADGLSPRL | 426 | O75132 | |
| NPNKPSAARSTEGSA | 3666 | Q5THJ4 | |
| NLGKNPDVDTSFLPD | 141 | Q9Y247 | |
| NAALAEAPSESKPAA | 366 | Q92539 | |
| DQGDKPALSLPLASF | 446 | Q496Y0 | |
| DLNLDSIQPATSPKG | 81 | Q58DX5 | |
| LPENSLSFQGSKDSP | 836 | E9PAV3 | |
| GAKAESNSNPISLPT | 1666 | Q5VU43 | |
| TPQKNSSSDLLLDFP | 236 | Q5VVJ2 |